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Abstract
Background: Glioblastoma multiforme (GBM) is one of most common and still poorly treated primary brain tumors. In
search for new therapeutic approaches, Bone Morphogenetic Proteins (BMPs) induce astroglial commitment in GBM-derived
cells in vitro. However, we recently suggested that hypoxia, which is characteristic of the brain niche where GBM reside,
strongly counter-acts BMP effects. It seems apparent that a more complete understanding of the biology of GBM cells is
needed, in particular considering the role played by hypoxia as a signaling pathways regulator. HIF-1a is controlled at the
transcriptional and translational level by mTOR and, alike BMP, also mTOR pathway modulates glial differentiation in central
nervous system (CNS) stem cells.
Methodology/Principal Findings: Here, we investigate the role of mTOR signaling in the regulation of HIF-1a stability in
primary GBM-derived cells maintained under hypoxia (2% oxygen). We found that GBM cells, when acutely exposed to high
oxygen tension, undergo Akt/mTOR pathway activation and that BMP2 acts in an analogous way. Importantly, repression of
Akt/mTOR signaling is maintained by HIF-1a through REDD1 upregulation. On the other hand, BMP2 counter-acts HIF-1a
stability by modulating intracellular succinate and by controlling proline hydroxylase 2 (PHD2) protein through inhibition of
FKBP38, a PHD2 protein regulator.
Conclusions/Significance: In this study we elucidate the molecular mechanisms by which two pro-differentiating stimuli,
BMP2 and acute high oxygen exposure, control HIF-1a stability. We previously reported that both these stimuli, by inducing
astroglial differentiation, affect GBM cells growth. We also found differences in high oxygen and BMP2 sensitivity between
GBM cells and normal cells that should be further investigated to better define tumor cell biology.
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Introduction
High-grade gliomas and particularly glioblastoma multiforme
(GBM), are the most common and most aggressive type of primary
brain tumor, accounting for 52% of all primary brain tumor cases.
Hypoxia plays a key role in normal homeostasis of stem cells [1]
and in the initiation, development and aggressiveness of gliomas,
lending support to the concept of a special tumor microenviron-
ment, in which hypoxia could be crucial to recruit cancer stem-like
cells, deregulating their differentiation [2,3]. BMPs treatment has
been recently considered a promising therapeutic approach for
brain cancer in order to reduce tumor cell growth. Indeed, BMP4
and analogously BMP2 treatment promotes cell cycle arrest and
glial differentiation in vitro in GBM-derived cells [4]. In a recent
work we demonstrated that hypoxia may preserve GBM-derived
cells in a more proliferative and less committed cell stage, by
down-regulating endogenous BMP signaling in tumor cells and
particularly SMAD 1/5/8 activation [3], providing evidence that
HIF-1a may counter-act BMP signaling activation under hypoxia.
Indication of hypoxia as a regulator of normal and tumor cells
growth comes also from other works, in which hypoxia has been
shown to induce carotid body growth and generation of new
neural crest derived glomus cells [1], while being implicated also in
the regulation of several signaling pathways, such as notch
signaling [5]. Moreover, HIF-1a expression seems to depend on
mammalian target of rapamycin (mTOR) signaling transcriptional
and translational control [6]. Furthermore, mTOR signaling
pathway seems to be activated also by BMP in murine CNS
precursor cells cultured at high density [7]; one of the possible
effects mediated by mTOR activation is serine phosphorylation of
Stat3, which finally leads to generation of glia [8]. Taken together
these data suggest a convergence of BMP with mTOR in
controlling glial differentiation and HIF-1a transcriptional activity.
Here we investigate the role of mTOR signaling in the regulation
of HIF-1a stability in primary GBM-derived cells maintained
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logical microenvironment [9], evaluating the effects mediated by
an acute raise of oxygen tension and by BMP2 treatment. Our
results indicate that hypoxia maintains mTOR pathway in an
inactive state and this occurs by preserving HIF-1a stability,
whereas an acute exposure to high oxygen tension and/or BMP2
treatment promote activation of Akt/mTOR and down stream
dependent pro-translational and pro-differentiating responses in
GBM cells, which undergo a metabolic shift, as shown by
increased of succinate dehydrogenase (SDH) activity following
these stimuli. Here we depict the molecular mechanisms occurring
in normal and tumor cells after high oxygen tension acute
exposure and BMP2 treatment.
Results
Acute exposure to high oxygen tension promotes Akt/
mTOR activation in a time dependent fashion in GBM-
derived cells
It has been previously shown that BMP2 increases Akt serine/
threonine kinase activity in serum-deprived 2T3 cells [10], and
Akt/PKB signaling is known to activate mTOR pathway.
Importantly, we have recently demonstrated that increasing
oxygen tension induces activation of endogenous BMP pathway,
through SMAD1/5/8 activation, in GBM-derived cells [3]. We
sought to investigate if a progressive time dependent exposure of
GBM cells, that have been constantly maintained under hypoxia
(2% oxygen), to an acute 20% oxygen tension, was promoting
Akt/mTOR signaling pathway activation. We observed activation
of Akt at the level of threonine 308, but not at the level of serine
473 (data not shown), in a time dependent fashion following high
oxygen exposure (Figure 1A,C). Also, mTOR phosphorylation at
the level of serine 2448 was induced by high oxygen exposure
(Figure 1A,D). Under constant hypoxia these activations were
inhibited. mTOR is known to regulate several biological cell
responses, amongst them: i) translation, through activation of
p70S6-Kinase (p70S6K) and inhibition of the inhibitor 4eBP1, ii)
cell proliferation, by acting as a cell cycle regulator, iii) cell survival
and cell differentiation, by Stat3 activation, iv) angiogenesis,
through activation of HIF-1a and Vascular Endothelial Growth
Factor (VEGF). We found that all mTOR downstream targets
were activated by acute high oxygen exposure in a time dependent
manner. Total Akt/mTOR proteins analyses indicated a homog-
enous expression among conditions both in GBM and normal cells
progressively exposed to high oxygen tension (Figure 1A,B).
Particularly, Stat3 (Ser727) was activated after 30 min of high
oxygen exposure (Figure 1A,E), this indicating gliogenesis [8] and/
or activation of pro-survival response [11]. Moreover, while 4eBP1
was only modestly inhibited by oxygen (data not shown), which
may be due to alternative regulatory pathways involved in 4eBP1
regulation, p70S6K (Thr389) was highly up-regulated especially
after 120 min (Figure 1A,F). These results indicate that activation
of Akt/mTOR dependent pro-translational pathways (p70S6K)
and gliogenic and pro-survival mechanisms (Stat3) occur in
response to acute high oxygen exposure. Moreover, this increase
in translation seems to be directed toward cell differentiation, as
indicated by increased p21
cip1 and increased endogenous BMP
dependent astroglial commitment as we reported earlier [3]. In
normal SVZ-derived cells Akt was only modestly and not
significantly activated by oxygen exposure, while mTOR activa-
tion occurred after 1 hr; although mTOR downstream targets
Stat3 and p70S6k were not activated following mTOR phosphor-
ylation (Figure 1B–F). These results indicate differences in normal
and tumour cell response to high oxygen tension exposure.
Another protein controlled by mTOR is HIF-1a [6]. We found
that HIF-1a was rapidly degraded by acute high oxygen exposure,
in both GBM and normal SVZ cells (Figure 2A–C). Although, a
modest recovery of HIF-1a protein was visible after 2 hr of high
oxygen exposure in GBM cells, but not in normal cells (Figure 2A–
C), indicating that tumour cells may re-establish HIF-1a level
through a hypoxic independent mechanism, possibly controlled by
mTOR progressive activation.
We also analyzed REDD1 (RTP801), which has been shown to
be strongly induced under hypoxic conditions in a HIF-1a
dependent manner [14] and recent studies also suggest that
REDD1 plays a role in the TSC1/TSC2-mediated inhibition of
mTOR [15]. Accordingly, we found REDD1 downregulated in
GBM cells, less intensively in normal SVZ cells, following acute
high oxygen exposure (Figure 2A,B,D). Thus, high oxygen
dependent Akt/mTOR signaling activation may occur after
HIF-1a/REDD1 downregulation.
HIF-1a is required to repress Akt/mTOR signaling
activation in hypoxic tumor cells
To understand if HIF-1a mediates the repressive effect of low
oxygen on Akt/mTOR signaling, we silenced HIF-1a using a
lentiviral vector containing siHIF-1a along with enhanced green
fluorescent protein as indicator of efficiency of transduction
(siHIF-1a-EGFP) (Figure 3A,D), which was compared to a
siLuciferase-EGFP vector (siLUC-EGFP) as a negative control
[3] (not shown). By silencing HIF-1a in GBM cells a strong
differentiation and eventually cell death occurred after 1 week,
as already reported in our previous work [3] and these effects
were not observed with siLUC-EGFP. Importantly, Akt,
mTOR, Stat3 and p70S6K were activated even in HIF-1a
silenced cells cultured at 2% oxygen compared to control group
and to GBM cells transduced with siLUC-EGFP vector
(Figure 3B,C). In normal SVZ cells HIF-1a silencing did not
elicit any significant effect and eventually Akt and mTOR
inhibition occurred compared to control (Figure 3E,F). HIF-1a
silencing correlates with a stronger BMP pathway activity in
GBM cells, as shown by SMAD1/5/8 phosphorylation [3], and
BMP pathway is known to activate Akt [10] and to be
correlated to Stat3 regulation in promoting astrogliogenesis [12].
These results indicate that HIF-1a in hypoxic tumor cells may
be required to repress convergent signals (SMAD1/5/8 and
Stat3) directed to promote an astroglial fate. To prove that HIF-
1a downregulation is required in evoking high oxygen
dependent Akt/mTOR activation we stabilized HIF-1a by
using cobalt chloride (CoCl2, 100 mM), which mimics the effect
of hypoxia on HIF-1a, and 12 hr later we exposed cells to high
oxygen tension. Performing these experiments directly on HIF-
1a silenced cells was not feasible given the scarce viability
following HIF-1a silencing. We found that by chemically
stabilizing HIF-1a, REDD1 was upregulated and Akt/mTOR
pathway was maintained inhibited in GBM derived cells exposed
to high oxygen tension (Figure 3G), only p70S6K activation did
occur and this may depend on effectors of p70S6K activation
alternative to mTOR. Importantly, normal SVZ cells responded
in a different way; indeed, by chemically stabilizing HIF-1a,
REDD1 was transiently upregulated and Akt/mTOR pathway
was not inhibited, unlike in tumor cells, following exposure to
high oxygen tension (Figure 3H), and Akt and Stat3 were
eventually upregulated by CoCl2. These results indicate that
HIF-1a stabilization, probably through REDD1, prevents high
oxygen induced Akt/mTOR activation, and this seems to occur
more specifically in GBM derived cells.
HIF-1a Stability in GBM Cells
PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6206Figure 1. GBM-derived cells undergo Akt/mTOR pathway activation after acute exposure to high oxygen tension. GBM precursors
derived cells and normal SVZ derived cells were initially expanded in 2% oxygen, followed by acute exposure to 20% oxygen for 30, 60 or 120
minutes. (A,B) Representative western blot analyses of activated Akt (T308), mTOR (S2448), p70S6K (T389), Stat3 (S727) and total proteins in GBM (A)
and normal SVZ cells (B). (C–F) Bar graphs showing mean intensity of indicated proteins normalized to control at 2% oxygen (corresponding to the 0
base line)6S.E.M. comparing 4 different tumors (black bars), n=3 for each tumor, with 3 different cultures of normal SVZ-derived cells (lighter bars),
n=3 for each culture. Statistical analyses were done comparing each time point for either GBM or normal cells to its respective T0 (0 min in 20% O2),
or as indicated by brackets.
doi:10.1371/journal.pone.0006206.g001
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promotes Akt/mTOR pathway activation and this
depends on HIF-1a/REDD1 downregulation
We sought to investigate if exogenous BMP2, alike acute high
oxygen exposure, could affect Akt/mTOR pathway activation.
While total Akt/mTOR signaling proteins resulted to be
homogenously expressed both in GBM and normal cells after
BMP2 treatment (Figure 4A and Figure S1A), we found that
activation of Akt (Thr308) and also mTOR (Ser2448) occurred
with time (Figure 4A,C,D), and, importantly, this activation was
accelerated and improved under acute high oxygen exposure,
remaining highly activated even after a long term BMP2 exposure
(72 hr) (Figure 4B). Importantly, under hypoxia Akt and mTOR
were inhibited after short time treatment, resulting activated after
72 hr of BMP2 stimulus. In normal SVZ cells we found that Akt
and mTOR were only transiently modulated by BMP2 addition
(Figure S1A,C,D) and after 72 hr these activations resulted down-
regulated (data not shown). Analyses of mTOR downstream
targets, revealed a time dependent increase of Stat3 (Ser727) and
p70S6K (Thr389) activation following BMP2 treatment, and these
effects were decelerated and decreased by maintaining cells under
hypoxia (Figure 4A,E,F), and this occurred transiently also in
normal cells (Figure S1A,E,F). Also p21
cip1, involved in cell cycle
arrest and induction of differentiation, was found up-regulated by
BMP2, but hypoxia inhibited this effects (data not shown).
HIF-1a expression is known to be controlled by mTOR [6] and
REDD1, mTOR inhibitor, is transcriptionally activated by HIF-
1a [14]. We analyzed if HIF-1a protein was affected following a
progressive BMP2 treatment and we found that HIF-1a was
strongly down-regulated even under hypoxia following 15 min of
BMP2 stimulation in GBM cells (Figure 5A,B). Importantly, HIF-
1a level was recovered after 120 min, however not when GBM
cells were also acutely exposed to high oxygen. This later
stabilization may be consequential to the BMP2 mediated mTOR
signaling activation (Figure 4A,B). According to our recent work
[3], HIF-1a level was reduced after a longer BMP2 exposure
(72 hrs) (not shown), which is likely correlated to BMP2 dependent
glial differentiation in GBM cells. Oppositely, maintenance of
HIF-1a expression seems to correlate to tumour cells de-
differentiation and normal cells primitiveness [5,13]. In normal
SVZ-derived cells HIF-1a was transiently down-regulated follow-
ing BMP2 stimulation and with time it was recovered (Figure
Figure 2. GBM-derived cells undergo transient HIF-1a and REDD1 degradation following acute exposure to high oxygen tension.
GBM precursors derived cells and normal SVZ derived cells were initially expanded in 2% oxygen, followed by acute exposure to 20% oxygen for 30,
60 or 120 minutes. (A,B) Representative western blot analyses of HIF-1a and REDD1 in GBM (A) and normal SVZ cells (B). (C,D) Bar graphs showing
mean intensity of HIF-1a and REDD1 normalized to control at 2% oxygen (corresponding to the 0 base line)6S.E.M. comparing 6 different tumors
(black bars), n=3 for each tumor, with 3 different cultures of normal SVZ-derived cells (lighter bars), n=5 for each culture.
doi:10.1371/journal.pone.0006206.g002
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treatment (data not shown). Importantly, also REDD1 was down-
regulated by BMP2 under hypoxia (Figure 5A,C), and this was
only transiently occurring in normal cells (Figure S1A). This
suggests that BMP2, analogously to an acute high oxygen
exposure, may promote mTOR activation by down-modulating
inhibitory REDD1.
As REDD1 is transcriptionally activated by HIF-1a [14], we
investigated if BMP2 besides modulating HIF-1a protein,
promoted also inhibition of HIF-1a transcriptional activity, by
Figure 3. Silencing of HIF-1a promotes Akt/mTOR pathway activation in GBM precursors but not in normal SVZ cells and HIF-1a
stabilization by CoCl2 maintains Akt/mTOR pathway inhibited following acute high oxygen exposure. (A,D) Representative pictures of
GBM (A) and normal SVZ cells (D) transduced using a lentiviral vector containing siHIF-1a along with enhanced green fluorescent protein (siHIF-1a-
EGFP) to test the effects of HIF-1a silencing. Same vector containing siLuciferase (siLUC-EGFP) was used to test for non-specific effects (pictures not
shown). Percentages of EGFP+ cells was determined by using cytofluorimeter (BD, FC500). (B–E) Representative western blot of HIF-1a silenced GBM
cells (B) and normal SVZ cells (E), analyzed for HIF-1a, Akt (T308), mTOR (S2448), p70S6K (T389) and Stat3 (S727), along with b-actin as a loading
control. (C,F) Bar graphs showing mean intensity of indicated proteins normalized to control at 2% oxygen (not transduced) (corresponding to the 0
base line)6S.E.M. comparing 2 different tumors (C), n=2 for each tumor and 1 normal SVZ-derived cell culture (F), n=2. Asterisks indicate statistically
significant differences comparing siHIF-1a to control at 2% oxygen (not transduced). (G,H) Representative western blot analyses of activated Akt
(T308), mTOR (S2448), p70S6K (T389), Stat3 (S727) and HIF-1a from GBM (G) and normal SVZ cells (H) that have been pre-incubated 12 hr with CoCl2
(100 mM, Sigma) prior to acute high oxygen exposure. 3 different GBM have been analyzed, n=2 for each tumor. 206 magnification pictures,
bar=50 mM.
doi:10.1371/journal.pone.0006206.g003
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construct. Despite a physiologic tumour samples variability, we
recorded a 40% reduction of HIF-1a transcriptional activity under
hypoxia following 8 hr of BMP2 treatment compared to untreated
cells. Conversely, in normal SVZ cells BMP2 was operating in an
opposite way, promoting a nearly 10% increase of HIF-1a activity
(Figure 5D), pointing to differences between normal and tumor
cells in BMP2 responsiveness.
We also tested if rapamycin treatment alone or in combination
with BMP2 to evaluate if blocking mTOR downstream signaling
affected also HIF-1a stability. We found that 72 hr of rapamycin
treatment, which did not affect HIF-1a transcriptional activition
(data not shown), induced a less pronounced HIF-1a protein
reduction, in accordance with reported results [16], whereas in
combination with BMP2 these effects were not further improved
(Figure 5E). Normal SVZ cells responded in a similar fashion (data
not shown).
To prove that Akt/mTOR activation was due to inhibition of
HIF-1a/REDD1 by BMP2, we performed BMP2 treatment on
CoCl2 pretreated GBM cells. We found that by stabilizing HIF-1a
and consequentially also REDD1, Akt/mTOR signaling was not
activated following BMP2 treatment (Figure 6A). p70S6K
activation lately occurred, probably due to effectors of p70S6K
activation alternative to mTOR, as commented above, and Stat3
Figure 4. Exogenous BMP2 promotes Akt/mTOR activation in GBM-derived cells and these effects are reduced by hypoxia. (A,B)
Representative western blot analyses of activated Akt (T308), mTOR (S2448), p70S6K (T389), Stat3 (S727) and total proteins; GBM-derived cells, initially
expanded in 2% oxygen were acutely exposed to 50 ng/ml BMP2 for 0, 15, 30, 60 or 120 minutes, either maintained at 2% or transferred at 20%
oxygen (A). Also, some GBM-derived cells were treated with 10 ng/ml BMP2 for longer time (72 hrs) (B). (C–F) Bar graphs showing mean intensity of
indicated proteins normalized to control at 2% oxygen (corresponding to the 0 base line)6S.E.M. comparing 5 different tumors, n=3 for each tumor.
doi:10.1371/journal.pone.0006206.g004
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although it was not modulated by BMP2 during time (Figure 6A).
Importantly, in normal SVZ cells, chemically HIF-1a stabilization
was only transiently inducing REDD1 upregulation and Akt/
mTOR pathway was not inhibited, unlike in tumor cells, following
BMP2 treatment (Figure S1B), and Akt and Stat3 were eventually
upregulated. Alternatively to the use of CoCl2, we used the
proteasome inhibitor Z-LLF-CHO (Z-LLF, 30 mM) added 30 min
prior to 8 or 24 hr of BMP2 time treatment under hypoxia. By
preventing proteasomal degradation, BMP2 did not affect HIF-1a
protein stability (Figure 6B). Moreover, REDD1 was upregulated
and Akt/mTOR signaling was not activated following BMP2
treatment under hypoxia (Figure 6B). These results confirm that
HIF-1a degradation and consequentially also REDD1 downreg-
ulation are required in BMP2 dependent Akt/mTOR activation,
and this preferentially occurs in GBM cells.
Exogenous BMP2 promotes increase of PHD2 protein
level even under hypoxia by dowregulating FKBP38
As we saw that HIF-1a protein stability was affected following
BMP2 treatment, we investigated if proline hydroxylases (PHDs),
involved in HIF-1a proline hydroxylation and consequential
proteasomal degradation, were modulated by BMP2. PHD2 in
particular has been described as the critical oxygen sensor setting
the low steady-state levels of HIF-1a in normoxia [17]. In the
same work PHD2 was found up-regulated by hypoxia, providing a
HIF-1-dependent auto-regulatory mechanism driven by oxygen
tension itself. We found that PHD2 protein was rapidly up-
regulated by BMP2, and this occurred more slowly under hypoxia,
in both GBM (Figure 7A,C) and normal SVZ cells (Figure S1A,H).
Also after a prolonged BMP2 treatment PHD2 protein resulted
up-regulated in GBM cells (Figure 7B), which is in accordance to
our previous work [3]. QRT-PCR revealed that while PHD2
transcript was up-regulated under hypoxia, according to literature
[17], 72 hr of BMP2 treatment induced a modest but not
significant PHD2 mRNA decrease (Figure 7D). PHD2 transcript
reduction was recorded also in BMP2 treated normal SVZ cells
(Figure S1I). Notably, PHD2 promoter is characterized by the
presence of HRE consensus sequences directly controlled by HIF-
1a [18]. Thus, we hypothesize that the observed PHD2 mRNA
reduction may depend on HIF-1a transcriptional inhibition
induced by BMP2, as previously described (Figure 5D).
Following-up on our observation that BMP2 mediated PHD2
protein increase was not dependent on de novo protein synthesis
(Figure 7D), we sought to investigate if BMP2 was somehow
increasing PHD2 protein stability. Peptidyl prolyl cis/trans
isomerase FK506-binding protein 38 (FKBP38) has been de-
scribed as a PHD2 protein regulator by targeting PHD2 to
proteasome degradation [19]. We found that FKBP38 was
progressively down-regulated by BMP2 under hypoxia
(Figure 7A,E), and this effect was observed also after a prolonged
BMP2 treatment (Figure 7B). Conversely to what has been
described [19], we also found that FKBP38 was up-regulated in
hypoxic GBM cells, suggesting that it may be involved in hypoxic
HIF-1a stability by promoting PHD2 degradation. QRT-PCR
analysis confirmed that FKBP38 was down-regulated by acute
exposure to high oxygen and by BMP2 under hypoxia also at the
transcriptional level (Figure 7F). Opposite, this was not occurring
in normal SVZ-derived cells in which BMP2 treatment combined
Figure 5. Exogenous BMP2 controls HIF-1a protein level and HIF-1a dependent transcriptional activity even under hypoxia. (A)
Representative western blot analyses of HIF-1a and REDD1; GBM-derived cells, initially expanded in 2% oxygen were treated as described in Fig. 4.
(B,C) Bar graphs showing mean intensity of HIF-1a and REDD1 normalized to control at 2% oxygen (corresponding to the 0 base line)6S.E.M.
comparing 6 different tumors, n=3 for each tumor. (D) HRE-luciferase assay: GBM cells and normal SVZ-derived cells were transfected either with a
HRE-firefly luciferase reporter construct or with a mutated HRE version of the same construct to evaluate aspecific effects. Along with these vectors,
also a Renilla luciferase vector has been transfected in order to normalize luciferase detection. Normalization of the data to the mutated HRE vector
was done and then values were calibrated to untreated cells (Control). 3 different GBM have been analyzed, n=2 for each tumor. (E) Representative
western blot analysis of HIF-1a in GBM-derived cells, initially expanded in 2% oxygen, then acutely exposed to 100 mM rapamycin alone or in
combination with 10 ng/ml BMP2 for 72 hrs. b-actin was used as a loading control. 2 different GBM have been analyzed, n=3 for each tumor.
doi:10.1371/journal.pone.0006206.g005
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(Figure S1J), also at the protein level (Figure S1A,K). Thus, we
hypothesize that BMP2 may promote PHD2 stabilization by
down-modulating FKBP38 expression in GBM cells.
Exogenous BMP2, by decreasing intracellular succinate,
increases PHD2 activity leading to HIF-1a modulation
We finally sought to investigate if BMP2 treatment increased
PHD2 activity thus causing HIF-1a modulation. It has been
previously reported that impaired SDH activity in several cancer
types is associated to HIF-1a stabilization, through a mechanism
involving intra-cytoplasmic succinate accumulation and conse-
quential PHD2 inhibition [20]. Indeed, SDH is the enzyme
complex II bound to the inner mitochondrial membrane that
converts succinate to fumarate via FAD reduction to FADH2.
Importantly, it has also been shown in other cell models that
induction of differentiation by BMPs increases mitochondrial
oxidative phosphorylation, as seen by higher SDH activity [21].
We found that BMP2 treatment induced increase of SDH activity
in GBM cells (Figure 8A,B). This suggests that pro-differentiating
agents, such as BMPs, may promote a metabolic shift toward
oxidative phosphorylation in tumor cells and that BMP2, by
decreasing intracellular succinate through induction of SHD
activation, may increase PHD2 activity leading to HIF-1a
modulation. Notably, in normal SVZ cells SDH activation was
not changed following BMP2 treatment (Figure S2A), this
indicating differences in metabolic response to BMP2 treatment
between normal and tumor cells. Further addition of exogenous
esterificated diethyl-succinate (5 mM, Sigma) either in presence or
absence of BMP2 did not induce SDH activation (not shown).
We also tested if additional succinate in combination with
BMP2, was promoting a recovery of HIF-1a protein level and/or
determining an inhibition of Akt/mTOR signaling in GBM cells.
We found that HIF-1a, REDD1 and FKBP38 proteins were
upregulated in BMP2/succinate treated cells, even when exposed
to 20% oxygen. Moreover, in particular Akt and p70S6K
activation were modestly decreased in presence of combined
BMP2 and succinate, as compared to BMP2 only treated cells
(Figure 8C). This indicates that additional succinate, by upregulat-
ing HIF-1a and REDD1, partially inhibits Akt/mTOR activation
following BMP2 treatment.
Discussion
HIF-1a and hypoxia have been shown to be implicated in
tumour progression [22–27]. We have recently shown [3] that
BMP2 in vitro treatment, known to promote glial differentiation in
GBM derived cells [4], resulted to be less effective under hypoxia,
suggesting that hypoxia and also HIF-1a may preserve GBM
tumour cell stemness by de-sensitizing cells to pro-differentiating
BMP2 stimulus [3]. It has also been reported that epigenetic-
mediated dysfunction of the BMP receptor-IB (BMPR-IB) inhibits
differentiation of glioblastoma-initiating cells [28], but the role of
hypoxia in BMP pathway regulation has not been previously
considered in other studies. Moreover, HIF-1a expression seems to
depend on mTOR signaling control [6] and mTOR seems to be
activated also by BMP in murine CNS precursor cells cultured at
high density [7]. These observations suggest a convergence of
BMP with mTOR in controlling glial differentiation and on the
other hand HIF-1a transcriptional activity. In this study we
investigated the role of mTOR signaling in the regulation of HIF-
1a stability in primary GBM-derived cells compared to normal
SVZ-derived cells, maintained under hypoxia, evaluating the
effects mediated by acute high oxygen exposure and BMP2. We
found that acute exposure to high 20% oxygen tension promotes
Akt and mTOR signaling pathways activation, with consequential
increase of mTOR downstream targets (Stat3 and p70S6K),
whereas hypoxia inhibits these effects. Importantly, under hypoxia
Akt/mTOR pathway results to be inhibited. p70S6K leads to
activation of pro-translational responses, which dependably leads
to increased differentiation. Accordingly, we also found Stat3,
known to promote astrogliogenesis [8], highly activated by acute
high oxygen tension. In a previous study it has been reported that
reactivation of Stat3 in PTEN-deficient glioblastoma cells inhibits
their proliferation and invasiveness [29]. We previously found that
after acute high oxygen exposure also SMAD1/5/8 activation,
known to induce astrogliogenesis, occurred [3], analogously to
Stat3 activation. Notably, normal SVZ-derived cells underwent
mTOR but not analogous Akt, Stat3 and p70S6K activation
following high oxygen acute exposure, suggesting differences in
oxygen sensitivity between tumour and normal cells. Importantly,
Figure 6. HIF-1a stabilization and consequential REDD1
upregulation maintains Akt/mTOR signaling inhibited in
BMP2 treated GBM derived cells. (A) Representative western blot
analyses of HIF-1a, REDD1, activated Akt (T308), mTOR (S2448), p70S6K
(T389), Stat3 (S727), along with b-actin as loading control; GBM cells
have been treated for 12 hr with CoCl2 (100 mM, Sigma) either at 2%
oxygen or 20% oxygen, starting progressive time course treatment with
BMP2 the day after. 2 different GBM have been analyzed, n=1 for each
tumor. (B) Representative western blot analyses of indicated proteins
extracted from GBM derived cells that have been pre-treated with Z-
LLF-CHO, proteasome inhibitor, added 30 min prior to BMP2 treatment
(for 8 or 24 hr). 2 different GBM have been analyzed, n=1 for each
tumor.
doi:10.1371/journal.pone.0006206.g006
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after 120 min it was partially reconstituted in GBM probably by a
mTOR dependent mechanism. Indeed, HIF-1a has been found to
be regulated by mTOR via a mTOR signaling motif, this leading
to increased angiogenesis [6]. Recent studies also indicate that
REDD1 (RTP801), induced under hypoxic conditions in a HIF-1a
dependent manner [14], plays a role in the TSC1 (hamartin)/
TSC2 (tuberin)-mediated inhibition of mTOR [15], these
indicating a reciprocal regulatory control between HIF-1a and
mTOR. Here we found that by stabilizing HIF-1a with CoCl2,
inhibition mTOR pathway was maintained following acute high
oxygen exposure on tumor cells, and this may occur through a
negative feedback loop dependent on HIF-1a mediated transcrip-
tional activation of REDD1. Accordingly, we found that silencing
of HIF-1a promotes stronger activation of Akt/mTOR even at
2% oxygen, analogously to inducing SMAD1/5/8 activity [3].
Together these results indicate that HIF-1a may be required to
repress besides SMAD1/5/8, also Akt and Stat3 activation in
hypoxic GBM cells, molecular signals directed toward induction of
astroglial fate in neural stem cells [30].
It has been shown that BMP2 increases Akt serine/threonine
kinase activity in serum-deprived 2T3 osteoblasts [10] and
accordingly we found that exogenous BMP2 treatment, analo-
gously to acute high oxygen exposure, induced up-regulation of
Akt/mTOR pathway, particularly of Stat3. Importantly, these
effects were downregulated both by hypoxia and by HIF-1a,
whose stabilization obtained with either CoCl2 or by using
proteasome inhibitor (Z-LLF) was preventing BMP2 induced Akt/
Figure 7. Exogenous BMP2 promotes increase of PHD2 protein level even under hypoxia by dowregulating FKBP38. (A,B)
Representative western blot analyses of PHD2 and FKBP38; GBM-derived cells, initially expanded in 2% oxygen were treated as described in Fig. 4.
Also, some GBM-derived cells were treated with 10 ng/ml BMP2 for longer time (72 hrs) (B). (C,E) Bar graphs showing mean intensity of PHD2 and
FKBP38 proteins normalized to control at 2% oxygen (corresponding to the 0 base line)6S.E.M. comparing 6 different tumors, n=3 for each tumor.
(D,F) QRT-PCR analyses of PHD2 and FKBP38, normalized to GUSB and then calibrated to 2% oxygen control (DDCt Method), mean6S.E.M. comparing
3 different GBM, n=3 for each tumor.
doi:10.1371/journal.pone.0006206.g007
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Akt, mTOR and its downstream targets were only transiently
modulated by BMP2, indicating a different sensitivity between
tumor and normal cells in responsiveness to exogenous BMP2.
Importantly, we also found that after 15 min of BMP2
treatment a rapid down-regulation of HIF-1a protein occurred
under hypoxia, but its level was recovered during time in GBM
cells. After a longer BMP2 treatment (72 hr), when glial
Figure 8. Exogenous BMP2 promotes higher SDH activity and addition of exogenous succinate upregulates HIF-1a/REDD1 and
FKBP38 proteins in BMP2 treated cells. (A) Representative citochemical analysis of SDH activity by using NBT reduction methodology. Cells were
incubated for 48 hr in presence of either BMP2 (30 ng/ml) or 3-nitropropionic acid (3-NPA) (500 mM, Sigma), known to irreversibly inactivate SDH
(negative control). (B) Bar graph showing mean percentage of SDH
+ cells (blue-violet cells) counted from 406 magnification pictures (picture
area=0.02 cm
2), bar=20 mM. 2 different tumors have been used, n=2 for each tumor. (C) Representative western blot analyses of indicated proteins
extracted from cells that have been treated 72 hr in presence of either BMP2 alone (10 ng/ml), or diethyl-succinate alone (5 mM, Sigma) or combined
BMP2 and diethyl-succinate. 2 different GBM have been analyzed, n=2 for each tumor.
doi:10.1371/journal.pone.0006206.g008
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[3] a reduction of HIF-1a protein, regardless the presence of
hypoxia, unlike in normal SVZ cells. We also found that following
BMP2 treatment REDD1, HIF-1a downstream target [14] and
mTOR inhibitor [15], was down-regulated even under hypoxia.
Thus, BMP2, analogously to an acute exposure to high oxygen
tension may promote mTOR activation by down-modulating
REDD1, as a consequence of HIF-1a dependent transcriptional
activity inhibition (Figure 5D).
PHD2 is involved in hydroxylation and consequentially
degradation of HIF-1a; we found that BMP2 induced increase
of PHD2 protein level, in both normal and tumour cells, but this
upregulation does not seem to be related to increased protein
translation. Moreover, FKBP38, which has been recently
described as a PHD2 protein modulator [19], was down-regulated
both by high oxygen exposure and BMP2 treatment in GBM cells
maintained under hypoxia. FKBP38 has been described to bind to
mTOR, inhibiting the ability of mTORC1 to signal to
downstream targets [31]. However, the molecular functions of
FKBP38 remain still elusive. We hypothesize that a decrease of
FKBP38 following BMP2 and high oxygen exposure may stabilize
PHD2 protein level leading to HIF-1a degradation even under
hypoxia. FKBP38 downregulation may also explain mTOR
signaling activation under these stimuli.
Since several decades it has been shown that solid tumor cells
are characterized by intense anaerobic glycolysis [32], strongly
suggestive of an association between mitochondrial dysfunction
and cancer. Indeed, a variety of tumor cell types are characterized
by an impaired respiratory capacity [32], and this was confirmed
also in our in vitro culture conditions, as shown by increased lactic
acid production and decreased cytochrome c oxidase activity
(COX) in GBM cells compared to normal SVZ cells (Figure
S2B,C). It has also been shown that mTOR pathway is influenced
by the intracellular concentration of ATP, independent from the
abundance of amino acids [33]. Thus, we hypothesize that mTOR
signaling down-regulation in our hypoxic GBM cells may be due
also to decreased ATP availability.
Among mitochondrial dysfunctions, impaired SDH activity in
several cancer types has been associated to non-hypoxic HIF-1a
stabilization, through a mechanism involving intracytoplasmic
succinate accumulation and consequential PHD2 inhibition
[20]. Importantly, it has also been shown in other cell models
that induction of differentiation by BMPs increases mitochon-
drial oxidative phosphorylation, as seen by higher SDH activity
[21]. Although, this effect has not been clearly described in
tumor cells. We found that SDH activity was increased
following BMP2 treatment, suggesting that pro-differentiating
agents, such as BMPs, may promote a metabolic shift toward
oxidative phosphorylation also in tumor cells. Addition of
succinate in combination with BMP2, was promoting a recovery
of HIF-1a protein, upregulation of REDD1 and consequentially
a moderate inhibition of Akt/mTOR signaling, especially of
p70S6K.
In conclusion, we describe the mechanisms by which BMP2
and, analogously, oxygen tension perturbation, by activating Akt/
mTOR signaling, inhibiting FKBP38 and by inducing SDH
activity modulate HIF-1a stability and consequentially REDD1
transcription in GBM cells. Together these effects are restrained
by preserving the hypoxic niche (Figure 9). Moreover, our results
point to discrete differences in high oxygen and BMP2 sensitivity
between GBM cells and normal cells that should be exploited to
better define tumor cell biology.
Figure 9. Summary of the hypothetical GBM cell responses to the niche. (A) Under hypoxia, brain tumor cells undergo HIF-1a stabilization,
due to PHD2 degradation probably mediated by FKBP38. Consequentially, HIF-1a dependent transcriptional control occurs, with inhibition of Akt/
mTOR signaling probably through REDD1 and TSC1/2. Moreover, HIF-1a inhibits SMAD1/5/8 activation [3]. Under hypoxia tumor cells remain in an
undifferentiated cell state [2]. (B) Raise of extracellular/intracellular oxygen tension and/or exogenous BMP2, or silencing of HIF-1a, besides activating
BMP signaling [3], promote activation of Akt/mTOR pathway. Consequentially mTOR induces activation of its downstream targets, such as Stat3 (pro-
survival, glial differentiation) and p70S6K (pro-translational responses). Under these conditions, HIF-1a, which is also controlled by mTOR at the
transcriptional and translational level, is down-regulated especially in the long term [3]. We showed that HIF-1a degradation is also related to BMP2
dependent increase of SDH activity, this leading to intracellular succinate level decrease and consequential PHD2 activation, in accordance with
previous report [20]. We hypothesize that BMP signaling, either independent or dependent on SMAD1/5/8 activation, may also down-regulate
FKBP38, thus impeding PHD2 proteasomal degradation and consequentially stabilizing PHD2 protein. Moreover, BMP2 dependent FKBP38
downregulation correlates also to activation of mTOR signaling, as FKBP38 is known to be a mTORC1 inhibitor [31].
doi:10.1371/journal.pone.0006206.g009
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Isolation and gas-controlled expansion of cells
Normal precursor cells were derived from brain subventricular
zone (SVZ) tissue of 3 premature neonates who died shortly after
birth (HuSC23, HuSC27 and HuSC30), previously characterized
[34] and hereafter termed normal SVZ precursors (see Table 1).
Ethics Statement: Written informed consent for the donation of
neonatal brain SVZ tissues was obtained from parents prior to
tissue acquisition, under the auspices of the protocol for the
National Human Neural Stem Cell Resource (NHNSCR)
approved by the Children’s Hospital of Orange County Institu-
tional Review Board. All tissues were acquired in compliance with
NIH and institutional guidelines.
GBM precursors were derived from 7 tumors taken at surgery
(see Table 1); initial pathological review was followed by secondary
neuropathological review to reconfirm diagnosis. Ethics State-
ment: Written informed consent for the donation of adult tumor
brain tissues was obtained from patients prior to tissue acquisition,
under the auspices of the protocol for the acquisition of human
brain tissues obtained from the Ethical Committee board of the
University of Padova and Padova Academic Hospital. All tissues
were acquired following the tenets of the Declaration of Helsinki.
We dissociated [35] and cultured cells on fibronectin-coated
dishes in DMEM/F12 (Irvine Scientific, Irvine, CA) supplemented
with BIT9500 (1% bovine serum albumin, 10 mg/ml insulin,
200 mg/ml transferrin; Stem Cell Technologies, CA), 20 ng/ml
basic fibroblast growth factor, (bFGF) and 20 ng/ml epidermal
growth factor (EGF, both human and from R&D Systems,
Minneapolis, MN) as previously described [36]. In vitro works are
generally not fully representative of a reliable physiological
condition. Although, a way to mimic tumor cell microenvironment
is providing a lowered oxygen tension, which is characteristic of
the solid tumor mass [9]; for this reason we cultured cells in an
atmosphere of 2%, 5% carbon dioxide and the balance nitrogen,
as previously described [36,37]. Analyses of some metabolic
parameters (i.e. lactate release and cytochrome c oxidase (COX)
activity) indicate that, despite the use of high glucose concentration
in our cell culture conditions (25 mM glucose), metabolic
differences between tumor and normal cells are clearly detectable
(Figure S2B,C). For continuous expansion, one-half of the medium
was replaced every day and cultures were passaged every 7–10
days using TrypLE (Invitrogen, Carlsbad, CA). Cells were not
cultured for more than 8 passages in vitro in order to avoid long
term culture related effects. In some experiments, cells were
supplemented with bone morphogenetic protein 2 (BMP2, 10 ng/
ml or 50 ng/ml, R&D Systems) or rapamycin (100 mM, Sigma).
Z-LLF-CHO (Z-LLF, Calbiochem, San Diego, CA), proteasome
inhibitor, was used at the concentration of 30 mM added 30 min
prior to BMP2 treatment. Esterificated diethyl-succinate (5 mM,
Sigma) was added either alone or in combination with BMP2
(10 ng/ml) for 72 hr. To stabilize HIF-1a cells have been pre-
treated for 12 hr with cobalt chloride (CoCl2, 100 mM, Sigma)
prior to starting progressive high oxygen exposure and/or time
course treatment with BMP2 the day after.
Western blot and densitometric analysis
Total protein extracts were isolated in lysis buffer as described
[37]. Equal amounts of protein (10–20 mg) were resolved using a
SDS-PAGE gels and transferred to PVDF Hybond-p membrane
(GE Healthcare), along with purified protein standard (Full Range
Rainbow
TM Molecular Weight Markers, from 10 to 250 kDa, GE
Healthcare) to insure qualitative accuracy of analyzed proteins.
Membranes were blocked with ECL Advance Blocking (Amer-
sham Pharmacia, 2%) or I-block
TM Blocking (Tropix, Sigma) for
at least 1 hour or overnight, under rotation at RT or 4uC
respectively. Membranes were then incubated overnight at 4uC
under constant shaking with the following primary antibodies: Akt
(rabbit, 1:1000, Cell Signaling), Akt (T308) (rabbit, 1:1000, Cell
Signaling), HIF-1a (mouse, 1:250, BD), mTOR (rabbit, 1:1000,
Cell Signaling), mTOR (S2448) (rabbit, 1:1000, Cell Signaling),
p70S6k (rabbit, 1:1000, Cell Signaling), p70S6K (T389) (rabbit,
1:1000, Cell Signaling), Stat3 (rabbit, 1:1000, Cell Signaling),
Stat3 (S727) (rabbit, 1:1000, Cell Signaling), PHD2 (goat, 1:300,
Santa Cruz), REDD1 (rabbit, 1:1000, Cell Signaling), FKBP38
(rabbit, 1:200, Acris Antibodies GmbH) and b-actin (mouse,
1:10000, Sigma). Membranes were next incubated with peroxi-
dase-labeled goat anti-rabbit IgG (Sigma, 1:100.000), peroxidase-
labeled goat anti-murine IgG (Sigma, 1:100.000) or donkey anti-
Table 1. Brain Tumors and Normal Neural Progenitor Cells used in study.
Code Tumor Type Age Gender
HuTuP01 Glioblastoma 65 male
HuTuP02 Glioblastoma 43 female
HuTuP10 Glioblastoma 75 female
HuTuP11 Glioblastoma 52 female
HuTuP13 Glioblastoma 67 male
HuTuP15 Glioblastoma 76 female
HuTuP47 Glioblastoma 81 female
Post-mortem review of non-tumour tissue source
HuSC23 Premature polycythemic twin (of a twin-to-twin transfusion) who died on the
day after birth
23 gw male
HuSC27 Premature infant who died of pulmonary complications 2 weeks after birth 23 gw male
HuSC30 Premature fraternal twin who died on the day after birth, product of in vitro fertilization 25 gw male
Brain tumours were acquired directly from surgery, dissociated and cells were expanded in culture. First neuropathological review of the tumour tissue was followed by
a second independent review. Patient ages listed in years (y). Non tumour tissue was from premature infants, listed in gestational weeks (gw), who died shortly after
birth; periventricular zone tissue from the head of the caudate nucleus was isolated and initially characterized by Schwartz et al. (2003); no gross or microscopic
abnormalities were observed at this time.
doi:10.1371/journal.pone.0006206.t001
HIF-1a Stability in GBM Cells
PLoS ONE | www.plosone.org 12 July 2009 | Volume 4 | Issue 7 | e6206goat IgG (Santa Cruz, 1:150.000) for 60 min. All membranes were
visualized using ECL Advance (GE Healthcare) and exposed to
Hyperfilm MP (GE Healthcare). Densitometric analysis of the
films was performed using Image J densitometer software. Values
were normalized to b-actin and calibrated to control at 2%
oxygen.
Real-Time PCR analysis
RNA was isolated from cells using Trizol (Invitrogen) and 1 mg
of total RNA reverse-transcribed using SuperScript RNAse H-
Reverse Transcriptase (Invitrogen). Quantitative RT-PCR reac-
tions were run in duplicate using BrilliantH SYBRH Green QPCR
Core Reagent Kit (Stratagene, La Jolla, CA). Fluorescent emission
was recorded in real-time (Sequence Detection System 7900HT,
Applied Biosystems, Foster City, CA, USA). Gene expression
profiling was completed using the comparative Ct method of
relative quantification. Relative RNA quantities were normalized
to beta-glucuronidase (GUSB) as a control and 2% oxygen,
untreated group, was used as the calibrating condition. PCR
amplification conditions consisted of 35 cycles with primers
annealing at 56uC. The specificity of primers (see Table 2) was
confirmed for every PCR run by dissociation curve analysis.
HRE-luciferase reporter assay
GBM cells and normal SVZ-derived cells were transfected using
a Promega Corporation (Madison WI) protocol for transient
transfection of adherent cells using Effectene reagent. HRE-
luciferase reporter construct used (wHRE) was kindly provided by
Dr. Indraccolo. It consists of a trimerized 24-mer containing 18 bp
of sequence from the PGK promoter including the HRE (59-
tgtcacgtcctgcacgactctagt, HRE) and an 8-bp linker sequence
followed by a 50-bp minimal tyrosine kinase promoter in a
pGL2-firefly luciferase basic Vector backbone (Promega) [38].
The mutant HRE (mHRE) construct used to evaluate aspecific
effects, has the ACG of the HIF-1 binding site mutated to CAT,
abolishing binding, as well as a point mutation that abolished a
BsgI restriction site for diagnostic purposes. GBM cells and normal
SVZ-derived cells were transfected either with a wHRE or with a
mHRE. Along with these vectors, also a Renilla luciferase vector
has been transfected in order to normalize luciferase detection
(Promega). 12 hr after transfection, total medium change was done
and cells were treated with 50 ng/ml BMP2 for 7 hrs. Finally, cells
were processed and analysis of HRE-luciferase activity was
performed as described (Dual-Luciferase Reporter Assay System,
Promega) by using a plate-reading luminometer (Victor, Perkin
Elmer).
Transduction of GBM cells using lentiviral vectors
The lentiviral plasmids containing HIF-1a siRNA and LUC
siRNA target sequences, termed pLSLG-HIF-1a-siRNA and
pLSLG-Luciferase-siRNA, respectively, were a kind gift of Dr.
O.V. Razorenova (Department of Molecular Cardiology, Lerner
Research Institute, Cleveland, OH) [39]. The lentiviral vectors
were produced as previously described [40] and used to infect
GBM cells and normal SVZ-derived cells. Target cells were
incubated with stocks for at least 12 hr. Transduced cells were
cultured for 5 days and analyzed by western blot.
Succinate dehydrogenase activity
To evaluate aerobic metabolic activity succinate dehydrogenase
(SDH) activity has been measured, since enzyme activity is
considered an indicator of tricarboxylic acid (TCA) cycle activity.
To measure SDH activity, we used the methods described by
Levine et al. with little modifications [41]. Briefly, frozen cell
monolayers (not fixed) were incubated for 20 min in the dark at
37uC in a reaction buffer containing 12.3 mM succinate (Sigma),
0.2 mM 1-methoxy-5-methylphenazine methyl sulphate (Sigma),
1.2 mM nitro blue tetrazolium (NBT, Sigma) in 50 mM Tris-HCl,
pH 7.6. We used 12.3 mM malonate (Sigma) to test aspecific
reactions, and we also tested 3-nitropropionic acid (3-NPA)
(500 mM, Sigma), known to irreversibly inactivate SDH, as
negative control. The enzyme activity is determined by measuring
the formation of nitro blue diformazan (NBT-dfz) due to NBT
reduction and the end product (i.e. blue cells) is visible by bright
field microscopy (Olympus IX50) or can be measured at 570 nm.
Lactate Assay
Extracellular lactate measurement was performed as directed
(BioVision) using a lactate assay kit kindly provided by Prof.
Burlina (Department of Paediatrics, University of Padova).
COX activity analysis
Cell pellets were resuspended in PBS and lysed by two freeze/
thaw cycles. COX activity was measured by the method of Salviati
and co-workers [42]. Bovine cytochrome c was reduced with
ascorbate and then desalted using a Sephadex G-25 column
(Amersham). The concentration of the reduced substrate was
determined spectrophotometrically at a wavelength of 550 nm.
Spectrophotometrical measurements were performed using a Cary
UV 100 spectrophotometer (Varian Inc., Walnut Creek, CA,
U.S.A.).
Statistical analysis
Graphs and statistical analyses were prepared using Prism 3.03
(Graph Pad). All values are presented as mean6standard error of
the mean (S.E.M.). Statistical significance was measured by one-
way ANOVA with Newman-Keuls multiple comparison post Test,
*p,0.05, **p,0.01, ***p,0.001. For all graphs, an asterisk
directly above a bar indicates a significant difference with its 2%
oxygen counterpart; an asterisk over a bracket indicates a
significant difference with another variable as indicated.
Supporting Information
Figure S1 (A) Representative western blot analyses of indicated
proteins; normal SVZ cells, initially expanded in 2% oxygen were
treated as described in Fig. 4 for GBM cells. (B) Representative
western blot analyses of indicated proteins extracted from normal
SVZ cells that have been treated for 12 hr with CoCl2 (100 mM,
Sigma) either at 2% oxygen or 20% oxygen, starting progressive
time course treatment with BMP2 the day after. (C-H, K) Bar
Table 2. Primer sets used for real-time PCR analysis.
Gene Primer Sequence Frag. Size
PHD2 F: 59-GGGACATTCATTGCCTCACT-39 158 bp
R: 59-ACACATGTGGTGCTTGCTGT-39
GUSB F: 59-GAAAATACGTGGTTGGAGAGCTCATT-39 101 bp
R: 59-CCGAGTGAAGATCCCCTTTTTA-39
FKBP38 F: 59-GGCTGTTGAGGAAGAAGACG-39 187 bp
R: 59-TCCATGAGTGGGACACTGAG-39
Sample preparation and amplification are described in Materials and Methods.
Abbreviations: F, forward primer; R, reverse primer; frag. size, fragment size; bp,
base pairs.
doi:10.1371/journal.pone.0006206.t002
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control at 2% oxygen (corresponding to the 0 base line)6S.E.M.
comparing 3 different normal SVZ cultures, n=3 for each one.
Statistical analyses were done comparing each time point at 2%
O2 to its respective time point at 20% O2. (I, J) QRT-PCR
analyses of PHD2 and FKBP38 normalized to GUSB and then
calibrated to 2% oxygen control (DDCt Method), mean6S.E.M.
comparing 2 different normal SVZ cultures, n=3 for each one.
Found at: doi:10.1371/journal.pone.0006206.s001 (1.08 MB TIF)
Figure S2 (A) Representative citochemical analysis of SDH
activity by using NBT reduction methodology in normal SVZ
cells, treated as described in Fig. 8A. (B) Bar graph showing
extracellular lactate measure comparing 3 different GBM cell
cultures and 2 different normal SVZ cell cultures. (C) Bar graph
showing cytochrome c oxidase (COX) activity comparing 3
different GBM cell cultures and 2 different normal SVZ cell
cultures. Cells have been either maintained under hypoxia or
exposed to acute high oxygen tension for 48 hr.
Found at: doi:10.1371/journal.pone.0006206.s002 (4.37 MB TIF)
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